Nordion (NDZ) jumps on BTG hook-up

Nordion Inc.  (NYSE: NDZ) shares hiked 8% to $7.69, on word the health-care company has entered into an agreement to divest its Targeted Therapies business to BTG plc an international specialist healthcare company based in the United Kingdom, for a cash purchase price of $200 million. Share volume was 25,000, compared to an all-day average of 39,000